Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis ; volume:66 ; number:8 ; day:12 ; month:5 ; year:2023 ; pages:1481-1500 ; date:8.2023
Diabetologia ; 66, Heft 8 (12.5.2023), 1481-1500, 8.2023
- Urheber
-
Yarmolinsky, James
Bouras, Emmanouil
Constantinescu, Andrei
Burrows, Kimberley
Bull, Caroline J.
Vincent, Emma E.
Martin, Richard M.
Dimopoulou, Olympia
Lewis, Sarah J.
Moreno, Victor
Vujkovic, Marijana
Chang, Kyong-Mi
Voight, Benjamin F.
Tsao, Philip S.
Gunter, Marc J.
Hampe, Jochen
Pellatt, Andrew J.
Pharoah, Paul D. P.
Schoen, Robert E.
Gallinger, Steven
Jenkins, Mark A.
Pai, Rish K.
Gill, Dipender
Tsilidis, Kostas K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-05925-4
- URN
-
urn:nbn:de:101:1-2023093011032484893760
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yarmolinsky, James
- Bouras, Emmanouil
- Constantinescu, Andrei
- Burrows, Kimberley
- Bull, Caroline J.
- Vincent, Emma E.
- Martin, Richard M.
- Dimopoulou, Olympia
- Lewis, Sarah J.
- Moreno, Victor
- Vujkovic, Marijana
- Chang, Kyong-Mi
- Voight, Benjamin F.
- Tsao, Philip S.
- Gunter, Marc J.
- Hampe, Jochen
- Pellatt, Andrew J.
- Pharoah, Paul D. P.
- Schoen, Robert E.
- Gallinger, Steven
- Jenkins, Mark A.
- Pai, Rish K.
- Gill, Dipender
- Tsilidis, Kostas K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomisation study
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study
Publisher Correction: Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Mendelian randomisation identifies priority groups for prophylactic EBV vaccination
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Stroke and frailty index: a two-sample Mendelian randomisation study
Proteomic associations with forced expiratory volume: a Mendelian randomisation study
A brief comparison of polygenic risk scores and Mendelian randomisation
Overlapping-sample Mendelian randomisation with multiple exposures: a Bayesian approach
Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomisation study
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study
Publisher Correction: Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Mendelian randomisation identifies priority groups for prophylactic EBV vaccination
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Stroke and frailty index: a two-sample Mendelian randomisation study
Proteomic associations with forced expiratory volume: a Mendelian randomisation study
A brief comparison of polygenic risk scores and Mendelian randomisation
Overlapping-sample Mendelian randomisation with multiple exposures: a Bayesian approach
Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomisation study
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study
Publisher Correction: Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
Mendelian randomisation identifies priority groups for prophylactic EBV vaccination
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Stroke and frailty index: a two-sample Mendelian randomisation study
Proteomic associations with forced expiratory volume: a Mendelian randomisation study
A brief comparison of polygenic risk scores and Mendelian randomisation